Filing Details

Accession Number:
0001209191-23-035618
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-09 08:00:14
Reporting Period:
2023-06-08
Accepted Time:
2023-06-09 08:00:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658247 Crinetics Pharmaceuticals Inc. CRNX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610381 Rogerio Coelho Vivaldi C/O Crinetics Pharmaceuticals, Inc.
10222 Barnes Canyon Road, Bldg 2
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-08 5,000 $22.06 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $22.06 per share. The range of actual purchase prices on the transaction date was $22.02 to $22.08 per share. Detailed information on the exact number of shares purchased at each price can be obtained from the issuer upon request.